| Baseline patient characteristics | NLR < 3.5 | NLR ≥ 3.5 | p-value |
| Sex |
|
|
|
| Male | 21 | 14 |
0.931 |
| Female | 18 | 10 | |
| Age |
|
|
|
| Average | 63.51 | 63.17 |
0.906 |
| Standard deviation | 10.933 | 11.620 | |
| Comorbidities |
|
|
|
| Hypertension | 30 | 16 | 0.550 |
| CAD | 7 | 4 | 1.000 |
| CVD | 2 | 1 | 1.000 |
| COPD | 0 | 2 | 0.275 |
| Body mass index (n = 58) | 24.8708 | 25.3595 |
0.509 |
| Standard deviation | 5.29279 | 4.49710 | |
| Medications |
|
|
|
| CaCO3 | 37 | 20 | 0.283 |
| ESA | 33 | 21 | 1.000 |
| Iron | 33 | 20 | 1.000 |
| DPPIV inhibitors | 21 | 16 | 0.459 |
| Calcium channel blockers | 22 | 12 | 0.814 |
| ARBS | 19 | 13 | 0.674 |
| Antiplatelet | 15 | 6 | 0.409 |
| ACEI | 12 | 8 | 1.000 |
| Nitrates | 11 | 5 | 0.723 |
| Insulin | 6 | 6 | 0.540 |
| Alpha 2 agonists | 7 | 2 | 0.491 |
| Statins | 5 | 1 | 0.487 |
| Sevelamer carbonate | 0 | 3 | 0.098 |